Breast cancer in Sub-Saharan Africa: opportunities for prevention

• Published in: Breast cancer research and treatment 2014-04, Vol.144 (3), p.467-478
• Main Authors: Brinton, Louise A., Figueroa, Jonine D., Awuah, Baffour, Yarney, Joel, Wiafe, Seth, Wood, Shannon N., Ansong, Daniel, Nyarko, Kofi, Wiafe-Addai, Beatrice, Clegg-Lamptey, Joe Nat
• Format: Article
• Language: English
• Subjects: Africa South of the Sahara - epidemiology; Breast cancer; Breast Neoplasms - epidemiology; Breast Neoplasms - etiology; Breast Neoplasms - prevention & control; Breast Neoplasms - therapy; Cancer; Cancer research; Cancer therapies; Comparative analysis; Disease prevention; Epidemiology; Female; Health aspects; Health Services Accessibility; Humans; Incidence; Medicine; Medicine & Public Health; Menopause; Mortality; Oncology; Prevention; Review; Risk Factors
• ISSN: 0167-6806; 1573-7217
• DOI: 10.1007/s10549-014-2868-z

Although breast cancer is a growing health problem in sub-Saharan Africa, reasons for its increased occurrence remain unclear. We reviewed the published literature to determine the magnitude of the increase in breast cancer, associated risk factors (including for breast cancer subtypes), and ways to reduce incidence and mortality. Some of the increased breast cancer occurrence likely reflects that women are living longer and adopting lifestyles that favor higher incidence rates. However, a greater proportion of breast cancers occur among premenopausal women as compared to elsewhere, which may reflect unique risk factors. Breast cancers diagnosed among African women reportedly include a disproportionate number of poor prognosis tumors, including hormone receptor negative, triple negative, and core basal phenotype tumors. However, it is unclear how lack of standardized methods for tissue collection, fixation, and classification contribute to these rates. Given appropriate classifications, it will be of interest to compare rates with other populations and to identify risk factors that relate to specific tumor subtypes. This includes not only risk factors that have been recognized in other populations but also some that may play unique roles among African women, such as genetic factors, microbiomata, xenoestrogens, hair relaxers, and skin lighteners. With limited opportunities for effective treatment, a focus is needed on identifying etiologic factors that may be amenable to intervention. It will also be essential to understand reasons why women delay seeking care after the onset of symptoms and for there to be educational campaigns about the importance of early detection.